SB Capital Management Inc Invests $11.54 Million in Capricor Therapeutics, Inc. $CAPR
SB Capital Management Inc purchased a new position in Capricor Therapeutics, Inc. (NASDAQ:CAPR – Free Report) in the 4th quarter, HoldingsChannel.com reports. The firm purchased 400,001 shares of the biotechnology company’s stock, valued at approximately $11,544,000. Capricor Therapeutics accounts for approximately 4.2% of SB Capital Management Inc’s investment portfolio, making the stock its 5th biggest […]
19 Jun 05:44 · The Cerbat Gem